The frequency of four common cancers in Kermanshah City, Iran, during the years 2004-2011
DOI:
https://doi.org/10.22122/cdj.v6i2.267Keywords:
Breast Cancer, Skin Cancer, Bladder Cancer, Stomach CancerAbstract
BACKGROUND: Cancer is one of the most prevalent diseases in today’s civilized world, with an increasing number of sufferers with each passing day. The aim of this study was to determine the prevalence of common cancers in Kermanshah City, Iran, in a period of eight years between 2004 and 2011.
METHODS: This was a historic cohort study. Data were collected from Kermanshah Province Health Center (Cancer Registry). Data analysis was performed using SPSS software.
RESULTS: 6,146 people were diagnosed with cancer in Kermanshah during these eight years. The prevalence of skin, stomach, breast, and bladder cancers, without considering the patients’ genders, was 35.24, 24.58, 23.73, and 16.45 percent, respectively. The highest frequency belonged to skin cancer with 309 persons in 2007.
CONCLUSION: Considering the fact that cancer has increased in the city of Kermanshah, it is necessary to change the lifestyle of all the people in order to prevent and reduce different types of cancer. Managers, officials, and health professionals are the most suitable individuals that can start changing the lifestyle, habits, and the improper way of living in this community.
References
Poormohammadi A, Karami M, Saedpanah K. Reducing the incidence of cancers in Iran with more attention to personal and environmental risk factors. Chron Dis J 2016; 4(1): 31-3.
Abdi A, Kolahi A, Naghavi M. Death diagnose mortality and morbidity in Iran: A guideline to general practitioners Tehran, Iran. Ministry of Health & Medical Education. Tehran, Iran: Simin Dokht Co; 2003. [In Persian].
Hajian K, Firouzjahi A, Kia MT. Pattern of Age Distribution of Different Cancers Babol, 2001. Pajouhesh Dar Pezeshki 2003; 27(3): 239-45. [In Persian].
Koosha A, Farahbakhsh M, Hakimi S, Abdolahi L, Golzari M, Seyf Farshad M. Epidemiologic Assessment of Cancer Disease in East Azerbaijan 2007. Med J Tabriz Univ Med Sci 2010; 32(4): 74-9. [In Persian].
Hasanpour Dehkordi A. Factors affecting quality of life in cancer patients under chemotherapy in Tehran (2004). Behbood J 2006; 10(2): 110-9. [In Persian].
Khasi K, Khasi B, Fakhri Moradi Aazam S, Khademi N. investigate frequency of breast cancer among women In Kermanshah during 2004-2013. Zanko J Med Sci 2016; 17(52): 28-34. [In Persian].
Heise K, Bertran E, Andia ME, Ferreccio C. Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol 2009; 15(15): 1854-62.
Mehrabi Y, Yavari P, Abadi A. A study of cancer patterns among inpatients of public hospitals in Iran. Asian Pac J Cancer Prev 2004; 5(4): 387-92.
Rahimi F, Heidari M. Time trend analysis of stomach cancer incidence in the west of Iran. Journal of Health and Development 2012; 1(2): 100-11. [In Persian].
Khasi B, Khasi K, Fakhri Moradi Azam S, Khademi N. Investigate plenty of bladder cancer in Kermanshah city during 2002-2011 YEARS. Zanko J Med Sci 2016; 16(51): 28-35. [In Persian].
McClendon BT, Prentice-Dunn S. Reducing skin cancer risk: An intervention based on protection motivation theory. J Health Psychol 2001; 6(3): 321-8.
Yazdanfar A, Ghasemi E. Frequency of skin cancers in Hamedan from 1991 to 2007. Dermatol Cosmet 2011; 2(2): 115-23. [In Persian].
Quinn AG, Perkins W. Non-melanoma skin cancer and other epidermal skin tumours. In: Burns T, Breathnach S, Cox N, Griffiths C, Editors. Rook's Textbook of Dermatology. Hoboken, NJ: Wiley; 2004.
Krejs GJ. Gastric cancer: Epidemiology and risk factors. Dig Dis 2010; 28(4-5): 600-3.
Khasi B, Khasi K, Khademi N, Fakhri Moradi Azam S. Investigate plenty of stomach cancer in Kermanshah city during 2004-2013 Years. Zanko J Med Sci 2016; 17(54): 16-22. [In Persian].
Fazeli Z, Najafian Zade M, Eshtati B, Almasi Hashiani A. Five-year evaluation of epidemiological, geographical distribution and survival analysis of breast cancer in Markazi Province, 2007-2011. J Arak Uni Med Sci 2014; 16(11): 73-80. [In Persian].
Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: An epidemiological review. Breast J 2007; 13(4): 383-91.
Azizi F, Hatami H, Janghorbani M. Epidemiology and control of common disordersin Iran. Tehran, Iran: Eshtiagh Publications; 2004. [In Persian].
Vedder MM, Marquez M, de Bekker-Grob EW, Calle ML, Dyrskjot L, Kogevinas M, et al. Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: An international validation in primary tumours. PLoS One 2014; 9(6): e96849.
Wu S, Li F, Huang X, Hua Q, Huang T, Liu Z, et al. The association of tea consumption with bladder cancer risk: A meta-analysis. Asia Pac J Clin Nutr 2013; 22(1): 128-37.
Busby JE, Kamat AM. Chemoprevention for bladder cancer. J Urol 2006; 176(5): 1914-20.
Pourabdian S, Janghorbani M, Khoubi J, Tahjvidi M, Mohebbi I. Relationship between high risk occupation particularly aromatic amines exposure and bladder cancer in Isfahan: A case-control study. J Urmia Univ Med Sci 2010; 21(2): 224-34. [In Persian].
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
van Lier EA, van Kranen HJ, van Vliet JA, Rahamat-Langendoen JC. Estimated number of new cancer cases attributable to infection in the Netherlands in 2003. Cancer Lett 2008; 272(2): 226-31.
Zolfaghari M, Bahramnezhad F, Parsa Yekta Z, Kazemnejad A, Monjamed Z. The life style risk factors of Tehran citizens associated with cancer prevention. J Shaheed Sadoughi Univ Med Sci 2013; 21(1): 28-36. [In Persian].
Melnick AL, Fleming DW. Modern geographic information systems-promise and pitfalls. J Public Health Manag Pract 1999; 5(2): viii-viix.
Wallberg P, Skog E. The increasing incidence of basal cell carcinoma. Br J Dermatol 1994; 131(6): 914-5.
Afzali M, Mirzaei M, Saadati H, Mazloomi-Mahmood-Abadi SS. Epidemiology of skin cancer and changes in its trends in Iran. Feyz 2013; 17(5): 501-11. [In Persian].
Douglas G, Leffell DJ. Squamous cell carcinoma. In: Wolff K, Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York, NY: McGraw-Hill; 2007.
Veisani Y, Delpisheh A, Sayehmiri K, Rahimi E. Survival rate estimation and its associated factors in patients with stomach cancer in Tohid Hospital in Sanandaj. Sci J Kurdistan Univ Med Sci 2013; 18(2): 1-8. [In Persian].
Keyhanian S, Farhadifar N, Fotoukian Z, Pouya M, Saravi M. Epidemiologic and malignancy indices of gastric cancer in patients referred to oncology clinic at Ramsar Emam Sajjad Hospital during 2002-2009. J Shaheed Sadoughi Univ Med Sci 2012; 20(1): 110-8. [In Persian].
Enayatrad M, Salehiniya H. Trends in gastric cancer incidence in Iran. J Mazandaran Univ Med Sci 2014; 24(114): 8-16. [In Persian].
Kerry R, Goovaerts P, Smit IP, Ingram BR. A comparison of multiple indicator Kriging and area-to-point Poisson Kriging for mapping patterns of herbivore species abundance in Kruger National Park, South Africa. Int J Geogr Inf Sci 2013; 27(1): 47-67.
Holakouei Naeini K, Ardalan A, Mahmoudi M, Motevallian A, Yahyapour M. Risk factors for breast cancer in Mazandaran province, 2004. J Sch Public Health Inst Public Health Res 2005; 4(1): 27-36.[In Persian].
Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A. International variations in bladder cancer incidence and mortality. Eur Urol 2014; 66(1): 59-73.
Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27(3): 289-93.
Akbarzadeh Pasha A, Mohammadi Kenari H, Alizadeh Navaei R, Hajian K. The incidence of bladder cancer in Mazandaran province for three years. J Babol Univ Med Sci 2012; 14(3): 80-4. [In Persian].
Madeb R, Messing EM. Gender, racial and age differences in bladder cancer incidence and mortality. Urol Oncol 2004; 22(2): 86-92.
